Histamine has the potential to inhibit interferon-γ (IFN-γ) signaling in melanoma (Kanda and Watanabe, 2002) and, therefore, could blunt Th1 immunity (Bradley et al., 1996). This evidence concerns the gene IFNG and melanoma.